Revvity, Inc. (NYSE:RVTY) Q1 2024 Earnings Call Transcript April 29, 2024 Revvity, Inc. beats earnings expectations. Reported EPS is $0.98, expectations were $0.94. Revvity, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello and welcome to the Q1 2024 […]
Related Keywords
China , Chinese , Max Krakowiak , Our Life Sciences Instrument , Tour Life Sciences , Specialty Pharma Services , Life Sciences , Reagents Technology Licensing , Our Signal Software , Revvity Omics Lab , Investor Relations , Life Sciences Instrument , Signal Software , Newborn Screening , Applied Genomics , Revvity , Steve Willoughby , Prahlad Singh ,
comparemela.com © 2020. All Rights Reserved.